Prot# INCB 08721-204: DECLARE 1 (DExelvucitabine Compared to Lamivudine in Anti-Retroviral Experienced Subjects-1)A Rndmzd, Dbl-Blnd, Phs II Study Comparing the Anti-Retroviral Safety & Efficacy of Dexelvucitabine(DFC)200mg 1x Daily to

Project: Research project

Project Details

StatusFinished
Effective start/end date5/18/06 → 5/1/07

Funding

  • PPD Development (INCB 08721-204 // INCB 08721-204)
  • Incyte Corporation (INCB 08721-204 // INCB 08721-204)